17 research outputs found
Serum lactate in refractory out-of-hospital cardiac arrest:Post-hoc analysis of the Prague OHCA study
Background: The severity of tissue hypoxia is routinely assessed by serum lactate. We aimed to determine whether early lactate levels predict outcomes in refractory out-of-hospital cardiac arrest (OHCA) treated by conventional and extracorporeal cardiopulmonary resuscitation (ECPR). Methods: This study is a post-hoc analysis of a randomized Prague OHCA study (NCT01511666) assessing serum lactate levels in refractory OHCA treated by ECPR (the ECPR group) or conventional resuscitation with prehospital achieved return of spontaneous circulation (the ROSC group). Lactate concentrations measured on admission and every 4 hours (h) during the first 24 h were used to determine their relationship with the neurological outcome (the best Cerebral Performance Category score within 180 days post-cardiac arrest). Results:In the ECPR group (92 patients, median age 58.5 years, 83% male) 26% attained a favorable neurological outcome. In the ROSC group (82 patients, median age 55 years, 83% male) 59% achieved a favorable neurological outcome. In ECPR patients lactate concentrations could discriminate favorable outcome patients, but not consistently in the ROSC group. On admission, serum lactate >14.0 mmol/L for ECPR (specificity 87.5%, sensitivity 54.4%) and >10.8 mmol/L for the ROSC group (specificity 83%, sensitivity 41.2%) predicted an unfavorable outcome. Conclusion: In refractory OHCA serum lactate concentrations measured anytime during the first 24 h after admission to the hospital were found to correlate with the outcome in patients treated by ECPR but not in patients with prehospital ROSC. A single lactate measurement is not enough for a reliable outcome prediction and cannot be used alone to guide treatment.</p
Hyperinvasive approach to out-of hospital cardiac arrest using mechanical chest compression device, prehospital intraarrest cooling, extracorporeal life support and early invasive assessment compared to standard of care. A randomized parallel groups ...
Out of hospital cardiac arrest (OHCA) has a poor outcome. Recent non-randomized studies of ECLS (extracorporeal life support) in OHCA suggested further prospective multicenter studies to define population that would benefit from ECLS. We aim to perform a prospective randomized study comparing prehospital intraarrest hypothermia combined with mechanical chest compression device, intrahospital ECLS and early invasive investigation and treatment in all patients with OHCA of presumed cardiac origin compared to a standard of care. Methods This paper describes methodology and design of the proposed trial. Patients with witnessed OHCA without ROSC (return of spontaneous circulation) after a minimum of 5 minutes of ACLS (advanced cardiac life support) by emergency medical service (EMS) team and after performance of all initial procedures (defibrillation, airway management, intravenous access establishment) will be randomized to standard vs. hyperinvasive arm. In hyperinvasive arm, mechanical compression device together with intranasal evaporative cooling will be instituted and patients will be transferred directly to cardiac center under ongoing CPR (cardiopulmonary resuscitation). After admission, ECLS inclusion/exclusion criteria will be evaluated and if achieved, veno-arterial ECLS will be started. Invasive investigation and standard post resuscitation care will follow. Patients in standard arm will be managed on scene. When ROSC achieved, they will be transferred to cardiac center and further treated as per recent guidelines. Primary outcome 6 months survival with good neurological outcome (Cerebral Performance Category 1–2). Secondary outcomes will include 30 day neurological and cardiac recovery. Discussion Authors introduce and offer a protocol of a proposed randomized study comparing a combined “hyper invasive approach” to a standard of care in refractory OHCA. The protocol is opened for sharing by other cardiac centers with available ECLS and cathlab teams trained to admit patients with refractory cardiac arrest under ongoing CPR. A prove of concept study will be started soon. The aim of the authors is to establish a net of centers for a multicenter trial initiation in future
Fast and accurate edge resource scaling for 5G/6G networks with distributed deep neural networks
International audienceNetwork slicing has been proposed as a paradigm for 5G+ networks. The operators slice physical resources from the edge, all the way to datacenter, and are responsible to micromanage the allocation of these resources among tenants bound by predefined Service Level Agreements (SLAs). A key task, for which recent works have advocated the use of Deep Neural Networks (DNNs), is tracking the tenant demand and scaling its resources. Nevertheless, for edge resources (e.g. RAN), a question arises whether operators can: (a) scale edge resources fast enough (often in the order of ms) and (b) afford to transmit huge amounts of data towards a cloud where such a DNNbased algorithm might operate. We propose a Distributed-DNN architecture for a class of such problems: a small subset of the DNN layers at the edge attempt to act as fast, standalone resource allocator; this is coupled with a Bayesian mechanism to intelligently offload a subset of (harder) decisions to additional DNN layers running at a remote cloud. Using the publicly available Milano dataset, we investigate how such a DDNN should be jointly trained, as well as operated, to efficiently address (a) and (b), resolving up to 60% of allocation decisions locally with little or no penalty on the allocation cost
Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT
Loss of expression of beta subunit of
succinate dehydrogenase (SDHB) was proved to be
present in a subgroup of KIT/PDGFRA wt gastrointestinal stromal tumors (GISTs). To evaluate possible
diagnostic utility of SDHB immunohistochemistry in the
differential diagnostics of mesenchymal tumors of
gastrointestinal tract (GIT), 11 cases of KIT/PDGFRA wt
GISTs, 12 gastric schwannomas (GSs), 20 solitary
fibrous tumors (SFTs), 4 leiomyomas (LMs), 16
leiomyosarcomas (LMSs), 5 synovial sarcomas (SSs), 3
endometrioid stromal sarcomas (ESSs), and 1 ileal
inflammatory myofibroblastic tumor (IMT) were
investigated for SDHB immunoexpression together with
molecular genetic analysis of genes encoding succinate
dehydrogenase (SDH). Three recent cases of
KIT/PDGFRA mutant GISTs were used as controls.
Among the 11 KIT/PDGFRA wt GISTs, 6 expressed
SDHB, 1 of them harboring a sequence change of
SDHD. All SDHB-negative cases were SDHB-D wt. In 1
of the control GIST cases molecular genetic analysis
revealed an SDHD sequence change in addition to a
mutation in KIT exon 11. No SFT was truly SDHBnegative, but in 2 of them the staining was impossible to
analyze. Furthermore, 1 SFT carried an SDHB and
another 1 SDHD sequence change. All GSs, LMs,
LMSs, SSs, ESSs, and IMT were SDHB-positive or nonanalyzable, and SDHB-D wt.
Additional factors may play a role in regulating
expression of SDHB. Furthermore, SDHB immunohistochemistry alone may be misleading in excluding
tumors other than GIST (especially SFT) in the
differential diagnosis of KIT/PDGFRA wt mesenchymal
tumors of GIT
Giardia mitosomes and trichomonad hydrogenosomes share a common mode of protein targeting
Mitochondria are archetypal organelles of endosymbiotic origin in eukaryotic cells. Some unicellular eukaryotes (protists) were considered to be primarily amitochondrial organisms that diverged from the eukaryotic lineage before the acquisition of the premitochondrial endosymbiont, but their amitochondrial status was recently challenged by the discovery of mitochondria-like double membrane-bound organelles called mitosomes. Here, we report that proteins targeted into mitosomes of Giardia intestinalis have targeting signals necessary and sufficient to be recognized by the mitosomal protein import machinery. Expression of these mitosomal proteins in Trichomonas vaginalis results in targeting to hydrogenosomes, a hydrogen-producing form of mitochondria. We identify, in Giardia and Trichomonas, proteins related to the component of the translocase in the inner membrane from mitochondria and the processing peptidase. A shared mode of protein targeting supports the hypothesis that mitosomes, hydrogenosomes, and mitochondria represent different forms of the same fundamental organelle having evolved under distinct selection pressures
CRT-127 Hyperinvasive Approach To Out-of Hospital Cardiac Arrest Using Mechanical Chest Compression Device, Prehospital Intraarrest Cooling, Extracorporeal Life Support And Early Invasive Assessment Compared To Standard Of Care. A Randomized Parallel Groups Comparative Study. “Prague Ohca Study". Results Of Presimulation And Simulation Phase
Hydrogenosome-localization of arginine deiminase in <i>Trichomonas vaginalis</i>
The arginine dihydrolase (ADH) pathway has an analogous function to the urea cycle in mitochondria-containing cells, by removing nitrogen from amino acids and generating ATP. Subcellular localization of the ADH pathway enzymes in Trichomonas vaginalis revealed that arginine deiminase (ADI) localizes to the hydrogenosome, a mitochondrion-like organelle of anaerobic protists. However the other enzymes of the ADH pathway, ornithine carbamyltransferase and carbamate kinase localize to the cytosol. Three gene sequences of T. vaginalis ADI (ADI 1–3) were identified in the T. vaginalis genome, all having putative mitochondrial targeting sequences. The ADI sequences were cloned and used to probe T. vaginalis using a carboxyterminal di-hemogglutinin epitope tag which demonstrated co-localization with malic enzyme confirming the hydrogenosome localization of this enzyme
Dysglycemia, glycemic variability, and outcome after cardiac arrest and temperature management at 33°C and 36°C
Objectives: Dysglycemia and glycemic variability are associated with poor outcomes in critically ill patients. Targeted temperature management alters blood glucose homeostasis. We investigated the association between blood glucose concentrations and glycemic variability and the neurologic outcomes of patients randomized to targeted temperature management at 33°C or 36°C after cardiac arrest. Design: Post hoc analysis of the multicenter TTM-trial. Primary outcome of this analysis was neurologic outcome after 6 months, referred to as "Cerebral Performance Category." Setting: Thirty-six sites in Europe and Australia. Patients: All 939 patients with out-of-hospital cardiac arrest of presumed cardiac cause that had been included in the TTM-trial. Interventions: Targeted temperature management at 33°C or 36°C. Measurements and Main Results: Nonparametric tests as well as multiple logistic regression and mixed effects logistic regression models were used. Median glucose concentrations on hospital admission differed significantly between Cerebral Performance Category outcomes (p < 0.0001). Hyper- and hypoglycemia were associated with poor neurologic outcome (p = 0.001 and p = 0.054). In the multiple logistic regression models, the median glycemic level was an independent predictor of poor Cerebral Performance Category (Cerebral Performance Category, 3-5) with an odds ratio (OR) of 1.13 in the adjusted model (p = 0.008; 95% CI, 1.03-1.24). It was also a predictor in the mixed model, which served as a sensitivity analysis to adjust for the multiple time points. The proportion of hyperglycemia was higher in the 33°C group compared with the 36°C group. Conclusion: Higher blood glucose levels at admission and during the first 36 hours, and higher glycemic variability, were associated with poor neurologic outcome and death. More patients in the 33°C treatment arm had hyperglycemia